← Back to Search

Soft Contact Lenses

CONTROL/TEST for Ocular Physiology

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1-week follow-up
Awards & highlights

Study Summary

This is a bilateral wear, dispensing, randomized, controlled, double-masked, 2-sequence ×2-period crossover study to evaluate ocular physiology following contact lens wear.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of Eyes With Grade 3 or Higher Slit Lamp Findings

Trial Design

2Treatment groups
Experimental Treatment
Group I: TEST/CONTROLExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (TEST/CONTROL) sequence and will wear two different study lenses one at a time over the two wear periods. During each wear period the lenses will be worn bilaterally for approximately 1 week. Study lenses will be worn for a minimum of 8 hours per day and at least 5 days per week during the wear period.
Group II: CONTROL/TESTExperimental Treatment2 Interventions
Eligible subjects that are habitual contact lens wearers will be randomized into the (CONTROL/TEST) sequence and will wear two different study lenses one at a time over the two wear periods. During each wear period the lenses will be worn bilaterally for approximately 1 week. Study lenses will be worn for a minimum of 8 hours per day and at least 5 days per week during the wear period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MyDay® Toric Soft Contact Lenses
2022
N/A
~80
PRECISION1® for Astigmatism Contact Lenses
2022
N/A
~80

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,483 Total Patients Enrolled
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,357 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~26 spots leftby Apr 2025